201. Evaluation of the Short and Long-term Impact of the COVID-19 Pandemic on Non-gynecological Cytology Practice.
- Author
-
Bilgi, Hülya, Durmuş, Şenay Erdoğan, Çomunoğlu, Cem, and Yalçın, Özben
- Subjects
- *
DISEASE risk factors , *COVID-19 pandemic , *MATERIALS handling , *URBAN hospitals , *CELLULAR pathology - Abstract
Objective: During the Coronavirus disease-2019 (COVID-19) pandemic, many screening and elective procedures were deferred, leading to a notable reduction in the volume of materials handled by the cytopathology laboratory. This study seeks to explore both the immediate and prolonged impacts of the pandemic on non-gynecologic cytology practices in a hospital, focusing on the timeframe beginning in March 2020, when the first case was identified in our country. Methods: Starting from March 2020, when our country reported its first COVID-19 case, we compared the percentages of cytological samples processed at the cytopathology laboratory of University of Health Sciences Turkey, Prof. Dr. Cemil Taşcıoğlu City Hospital, for the three-month period of March to May in 2020 with those from the same months in 2019, 2021, and 2022. We also assessed the differences in malignancy rates. Results: In the three-month study period of 2020, there was an 81.5% reduction in the total number of non-gynecologic cytological specimens compared to 2019. Conversely, the overall malignancy rate saw a significant increase (6.1% in 2019 and 10.8% in 2020). During the 3-month study period in 2021, cytologic specimens increased compared with 2020 (127.8%) but continued to decrease compared with 2019 (-57.8%). In 2021, the overall malignancy rate was higher than that in other years (12.5%). Similarly, in the 3-month period in 2022, cytologic samples increased compared with 2020 (221.6%), but despite this increase, the number of cases was still lower than in the pre-pandemic period (-40.5%). The overall malignancy rate continued to be higher than before the pandemic (2019: 6.1%, 2022: 10.1%). Conclusion: The delay of elective procedures due to the COVID-19 pandemic has had a major impact on cytopathology practices. In both 2021 and 2022, the volume of non-gynecologic cytologic materials remained significantly lower than in 2019, highlighting the ongoing effects of the pandemic on cytopathology. Meanwhile, the rise in the overall malignancy rate underscores the need to prioritize diagnostic procedures for patients at high risk for cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF